Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-28

Clinical Trial Update: Magnesium Sulfate for Analgesia in Pediatric Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating magnesium sulfate as analgesia in pediatric transplant recipients has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University of Minnesota | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2024-10-28